Autologous stem cell transplantation (ASCT) is a key therapeutic strategy for many patients diagnosed with multiple myeloma (MM), yet early relapses post-transplant remains a major clinical challenge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results